News Factory Provides the Latest and Most Up-to-Date News, You Can Stay Informed and Connected to the World.
⎯ 《 News • Factory 》

List of All Articles with Tag '3400398z'

Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 07:17
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:20
Sanofi Is Exploring Acquisition of Cancer Drugmaker Mirati
Sanofi Is Exploring Acquisition of Cancer Drugmaker Mirati
French pharmaceutical firm Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people
2023-10-06 17:51
Nestle Divests Peanut-Allergy Drug on Disappointing Uptake
Nestle Divests Peanut-Allergy Drug on Disappointing Uptake
Nestle SA sold its peanut-allergy medicine business to Swiss health-care group Stallergenes Greer after the food company gave
2023-09-04 14:55
Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum
2023-08-07 20:15
Astellas Pharma Secures US FDA Approval for Izervay
Astellas Pharma Secures US FDA Approval for Izervay
The US Food and Drug Administration approved Astellas Pharma Inc.’s Izervay for the treatment of age-related macular degeneration,
2023-08-05 10:54
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
2023-08-03 10:17
Biogen to Buy Reata for $7.3 Billion in Rare-Disease Deal
Biogen to Buy Reata for $7.3 Billion in Rare-Disease Deal
Biogen Inc. agreed to acquire Reata Pharmaceuticals Inc. for $7.3 billion, including debt, to expand its rare disease
2023-07-28 22:57
Artificial Sweetener Aspartame Is ‘Possibly’ Carcinogenic, Yet Safe at Common Use Levels, WHO Says
Artificial Sweetener Aspartame Is ‘Possibly’ Carcinogenic, Yet Safe at Common Use Levels, WHO Says
Aspartame, the artificial sweetener found in everything from diet drinks, yogurt, ice cream and breakfast cereals to medicines,
2023-07-14 06:51
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move that will help widen insurance
2023-07-07 08:48
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:46
Guns for Domestic Abusers, Agency Power Next Up at Supreme Court
Guns for Domestic Abusers, Agency Power Next Up at Supreme Court
The Supreme Court is already planning to dive back into the culture wars and tackle the power of
2023-07-02 23:51
«12»